scholarly journals A Role for Vascular Deficiency in Retinal Pathology in a Mouse Model of Ataxia-Telangiectasia

2011 ◽  
Vol 179 (3) ◽  
pp. 1533-1541 ◽  
Author(s):  
Dorit Raz-Prag ◽  
Ronit Galron ◽  
Niva Segev-Amzaleg ◽  
Arieh S. Solomon ◽  
Yosef Shiloh ◽  
...  
2019 ◽  
Vol 132 (5) ◽  
pp. jcs223008 ◽  
Author(s):  
Valentina Tassinari ◽  
Vincenzo De Gennaro ◽  
Gina La Sala ◽  
Daniela Marazziti ◽  
Giulia Bolasco ◽  
...  

2020 ◽  
Author(s):  
Harvey Perez ◽  
May F. Abdallah ◽  
Jose I. Chavira ◽  
Martin T. Egeland ◽  
Karen L. Vo ◽  
...  

AbstractAtaxia Telangiectasia (A-T) is caused by null mutations in the genome stability gene, ATM (A-T mutated). In mice, similar null mutations do not replicate A-T’s characteristic severe ataxia with associated cerebellar dysfunction and atrophy. By increasing genotoxic stress, through the insertion of null mutations in the Atm (nonsense) and related Aptx (knockout) genes, we have generated a novel A-T mouse that first develops mild ataxia, associated with abnormal Purkinje neuron (PN) activity and decreased size, progressing to severe ataxia correlated with further reduced PN activity as well as PN loss and overall cerebellar atrophy. These mice also exhibit high incidences of cancer and immune abnormalities that are all hallmarks of the human disorder. Enabled by the insertion of a clinically relevant nonsense mutation in Atm, we demonstrate that small molecule readthrough (SMRT) compounds can restore ATM production, indicating their potential as a future A-T therapeutic.


2019 ◽  
Vol 9 (1) ◽  
Author(s):  
Paul Ibbett ◽  
Srinivas V. Goverdhan ◽  
Elena Pipi ◽  
Joe K. Chouhan ◽  
Eloise Keeling ◽  
...  

2013 ◽  
Vol 21 (1) ◽  
pp. 42-48 ◽  
Author(s):  
Anthony D D'Souza ◽  
Ian A Parish ◽  
Diane S Krause ◽  
Susan M Kaech ◽  
Gerald S Shadel

2007 ◽  
Vol 293 (1) ◽  
pp. E70-E74 ◽  
Author(s):  
Philip D. Miles ◽  
Kai Treuner ◽  
Marc Latronica ◽  
Jerrold M. Olefsky ◽  
Carrolee Barlow

Ataxia telangiectasia (A-T) is an autosomal recessive disease caused by mutations in the A-T mutated (ATM) gene. The gene encodes a serine/threonine kinase with important roles in the cellular response to DNA damage, including the activation of cell cycle checkpoints and induction of apoptosis. Although these functions might explain the cancer predisposition of A-T patients, the molecular mechanisms leading to glucose intolerance and diabetes mellitus (DM) are unknown. We have investigated the pathogenesis of DM in a mouse model of A-T. Here we show that young Atm-deficient mice show normal fasting glucose levels and normal insulin sensitivity. However, oral glucose tolerance testing revealed delayed insulin secretion and resulting transient hyperglycemia. Aged Atm−/− mice show a pronounced increase in blood glucose levels and a decrease in insulin and C-peptide levels. Our findings support a role for ATM in metabolic function and point toward impaired insulin secretion as the primary cause of DM in A-T.


Redox Biology ◽  
2018 ◽  
Vol 14 ◽  
pp. 645-655 ◽  
Author(s):  
Ruth Duecker ◽  
Patrick Baer ◽  
Olaf Eickmeier ◽  
Maja Strecker ◽  
Jennifer Kurz ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document